FDA Authorizes New COVID-19 Vaccines for Upcoming Season

AI-generated NewsSnap summary based on source reporting.
Published: 2026-09-07
Category: health
Source: Healthline
Original source

The FDA has approved four updated COVID-19 vaccines from Moderna, Novavax-Sanofi, and Pfizer-BioNTech for the 2026-2027 season. These vaccines target the JN.1-lineage XFG variant and are authorized for adults 65 and older, plus younger individuals with high-risk conditions. This aims to bolster protection against circulating variants ahead of fall and winter.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai